Cargando…
Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells
Gastric cancer is the most common digestive tract malignancy in China and has a poor prognosis, with a 5-year overall survival rate of only 35.1%. Because its early symptoms are not obvious and early diagnosis is complicated, there is an urgent need to find biological targets for diagnosis and treat...
Autores principales: | Di, Ji, Jiang, Bo, Shang, Hao, Yang, Xin, Zhang, Chengwu, Shi, Xiali, Chai, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356858/ https://www.ncbi.nlm.nih.gov/pubmed/35992548 http://dx.doi.org/10.1155/2022/1426343 |
Ejemplares similares
-
Retracted: Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Liu, Ying, et al.
Publicado: (2021) -
Albendazole Exhibits Anti-Neoplastic Actions against Gastric Cancer Cells by Affecting STAT3 and STAT5 Activation by Pleiotropic Mechanism(s)
por: Yang, Min Hee, et al.
Publicado: (2021) -
RING-Finger Protein 6 promotes Drug Resistance in Retinoblastoma via JAK2/STAT3 Signaling Pathway
por: Chai, Yong, et al.
Publicado: (2022) -
Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells
por: Okamoto, W, et al.
Publicado: (2011)